Innospec Inc (IOSP) maintains a long-term positive bias despite neutral near-term readings. AI models propose trading strategies including momentum breakouts and risk-hedging with a 26.9:1 risk-reward
Innospec Inc. shares reached a 52-week high of $95.07 following strong Q2 2026 financial results that surpassed earnings and revenue expectations.
Innospec Inc met Q2 2023 EPS expectations at €1.11 but missed revenue projections by €13.47 million, reporting €415.77 million with 2.74% YoY growth. Next earnings are scheduled for November 10, 2026.
Innospec reported strong first-half 2026 results with increased sales and net income, alongside ongoing share repurchase activities. Analysts suggest the stock may be 6% undervalued following these fi
Innospec Inc. reported strong Q2 2026 earnings and completed a $34.87 million share repurchase program. The company focuses on specialized chemicals earnings despite raw material volatility.
Innospec Inc reported Q1 2024 earnings with an EPS beat of $1.75 against consensus, while revenue of $500.20 million slightly missed expectations. The release includes access to the earnings call and
Innospec Inc. shares reached a 52-week high of $94.67 following strong Q2 2026 financial results that exceeded earnings and revenue expectations despite near-term supply constraints.
Innospec reported Q2 2026 sales of US$491.4 million, achieving a debt-free balance sheet that drove a 7.5% stock rise. While authorizing a US$75 million share repurchase, the company noted risks from
Innospec Inc. released its Q2 2026 earnings call presentation, reporting EPS of $1.27 and revenue of $491.40 million, surpassing analyst estimates.
Innospec Inc. reported second-quarter 2026 adjusted earnings of $1.27 per share and revenues of $491.4 million, surpassing consensus estimates. Growth was broad-based across its Performance Chemicals,
The Public Employees Retirement System of Ohio significantly reduced its stake in Innospec Inc. by 96.6% in Q1, even as the company reported strong quarterly earnings beating analyst estimates.
Janus Henderson Group PLC reduced its stake in Innospec Inc. by 11.7% in Q1, while other institutions increased positions. Innospec reported strong quarterly earnings with $1.27 EPS and 11.8% revenue
Innospec Inc reported strong Q2 2026 earnings with double-digit sales growth, despite margin pressures from supply constraints. Management plans facility expansions by late 2026 to boost capacity and
Innospec reported strong Q2 2026 financial results with revenue rising 12% to $491.4 million. Net income reached $30.8 million while maintaining a debt-free balance sheet and returning capital to shar
Innospec Inc stock reached a new 52-week high of $92.31 following strong Q2 2026 results that exceeded analyst expectations with $1.27 adjusted EPS. The company holds a $2.26 billion market cap, with
Innospec Inc. reported strong Q2 2026 results with revenue of $491.4 million and EPS of $1.25. Growth was driven by volume gains in Fuel Specialties and Performance Chemicals segments alongside operat
Innospec Inc exceeded Q2 2026 forecasts with adjusted EPS of $1.27 and revenue of $491.4 million, driving a 2.7% stock rise. Management highlighted double-digit segment growth and plans to boost Perfo
Innospec reported strong Q2 2026 earnings with 12% revenue growth to $491.4 million, while Performance Chemicals capacity is set to increase by over 10% following plant repairs.
Innospec Inc. reported strong second-quarter 2026 financial results, with revenues rising 12% to $491.4 million driven by Fuel Specialties and Performance Chemicals segments. The company maintained a
Innospec Inc has released its earnings summary for the quarter ended June 30. The full article is available through Refinitiv on TradingView for subscribers.
Innospec Inc. reported Q2 adjusted EPS of $1.27 and revenue of $491.4 million, both exceeding analyst estimates. These results indicate strong financial performance for the company in the second quart
Innospec Inc. shares declined 1.19% to $84.875 with a $2.10 billion market cap. Analysts maintain a 'Buy' rating with a $99.33 target price, citing strong fundamentals in the Chemicals industry.
Innospec Inc (IOSP) ranks 20th in the Chemicals industry with a financial score of 7.76. Quarterly revenue hit $453.20 million, up 2.81% YoY, while net profit increased by 7.32%.
Innospec Inc reports $134.40 million in total dividends over five years, providing a detailed timeline of payout dates and stock split events.
Innospec Inc details its major institutional shareholders including BlackRock and Vanguard, outlining shareholding trends and ETF holdings over recent quarters.
Innospec Inc publishes a detailed cash flow analysis breaking down operating, investing, and financing activities across various fiscal quarters. Key financial figures including net income and capital
Innospec Inc stock maintains gains backed by strong Q1 2024 earnings, including a 3.8% revenue increase and 10% rise in adjusted operating income. Resilient margins in fuel specialties and performance
Innospec Inc. posted stable fiscal 2023 results featuring modest revenue growth and improved operating cash flow. Performance chemicals sustained profitability, supporting consistent dividends and sha
Innospec Inc reported fiscal 2024 revenue of $1.8 billion, up 6%, driven by its Performance Chemicals segment. Adjusted EPS rose 11% to $5.20, reflecting disciplined capital allocation and strong cash
Innospec Inc shares trade below fair value following removal from Russell growth indices. The company maintains a strong cash position and focuses on specialty chemicals and battery chemistry markets.
Specialty chemicals maker Innospec Inc is identified as a potential acquisition target valued between $2.4 billion and $2.8 billion. Potential buyers such as NewMarket, SLB, and Ecolab are highlighted
Innospec Inc remains a Nasdaq-listed specialty chemicals firm focused on fuel additives and performance chemicals, linking operations to refinery activity and industrial end markets.
Innospec Inc. announced its Q2 2026 earnings release on August 4, followed by an investor conference call on August 5 at 10:00 a.m. ET. Registration is required for access to the audio webcast.
Innospec Inc. will release its second-quarter 2026 earnings on August 4, 2026, followed by an executive conference call on August 5. The company manufactures specialty chemicals, fuel specialties, and
Innospec Inc shares closed at $83.10 on July 2, rising 1.63%. The report details key financial metrics such as market cap, dividends, and trading volumes for the specialty chemical manufacturer.
Innospec Inc. released its 2025 Sustainability Report, detailing progress in emissions reduction, safety, and R&D investment while reaffirming its commitment to sustainable business growth.
Innospec Inc. appears undervalued following its removal from Russell indexes, trading at a 25% discount despite strong performance in Fuel Specialties and Performance Chemicals. However, investors fac
Innospec released its 2025 Sustainability Report, highlighting a 6% reduction in employee accidents and a 34% decrease in GHG emissions since 2014. The company also achieved 100% renewable electricity
Innospec Inc. (NASDAQ: IOSP) financial data highlights its enterprise value to EBITDA forward metric as a specialty chemical manufacturer.
This resource details financial actuals and estimates for Innospec Inc., covering stock metrics, earnings, revenue, and analyst forecasts. It serves as a financial performance overview for the special
Innospec Inc reported regional revenue data as of April 6, with the United States contributing 53.53% and the United Kingdom 44.61%. Detailed profit contribution by business segment remains undisclose
Innospec Inc distributed $134.4 million USD in dividends over the past five years via semi-annual payments. Currently, no relevant data is available regarding stock splits for the company.
This data page tracks shareholder information for Innospec Inc. (NASDAQ: IOSP), a specialty chemical firm, though specific figures are not detailed in the snippet.
Innospec Inc has appointed Shelley Bausch as a Class II director and Audit Committee member effective July 1, 2026, expanding its board to eight members.
Innospec Inc company profile introduced, noting no specific operational or financial details are currently available in the document.
Innospec Inc.'s $75 million share repurchase program has expired as of May 2026. The company also reported Q1 2026 earnings and declared a semi-annual dividend.
Innospec Inc. reported a 3% year-over-year revenue increase to $453.2 million in Q1 2026, while announcing an increased semi-annual dividend and a $75 million share repurchase program.
Innospec announced a $75 million share buyback and a 10% dividend increase, highlighting capital returns amidst a stock decline. The specialty chemical firm is deemed undervalued, though its valuation
Innospec Inc will trade ex-dividend on May 19, 2026, with a cash dividend of $0.92 per share payable on May 29, 2026.
Innospec Inc. will go ex-dividend on May 19th with a $0.92 per share payment. The company maintains strong dividend sustainability supported by a 37% earnings payout ratio and 32% annual earnings grow
ChemBrief